等待开盘 04-02 09:30:00 美东时间
0.000
0.00%
Strategic Update:As discussed previously, Glimpse's Board of Directors has approved a formal process of exploring and pursuing various strategic alternatives, all aimed at unlocking and maximizing Glimpse shareholder
02-17 21:33
The earnings results for Glimpse Group (NASDAQ:VRAR) for Q2 were made public on...
02-17 21:32
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likel...
02-17 19:11
Glimpse Group (NASDAQ:VRAR) will release its quarterly earnings report on Tuesd...
02-17 05:01
Glimpse Group ( ($VRAR) ) has provided an update. On December 18, 2025, The Gli...
2025-12-22 22:57
今日重点评级关注:Ascendiant Capital:维持Society Pass"买入"评级,目标价从22美元升至22.5美元;HC Wainwright & Co.:维持Climb Bio"买入"评级,目标价从9美元升至11美元
2025-12-19 10:15
WestPark Capital analyst Casey Ryan reiterates Glimpse Group (NASDAQ:VRAR) with a Buy and maintains $2.62 price target.
2025-12-19 00:24
Glimpse Group (VRAR) plans a $100 million offering of common stock, preferred stock, debt, and warrants, it said in a filing. More on The Glimpse Group The Glimpse Group, Inc. (VRAR) Q1 2026 Earning...
2025-11-24 17:19
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
2025-11-13 19:11
Glimpse Group (NASDAQ:VRAR) will release its quarterly earnings report on Thurs...
2025-11-13 02:03